ArticleCancer medicine2024

Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies.

Kira Vordermark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.